La Fundación 'la Caixa' impulsa dos proyectos biomédicos de CIC bioGUNE para trasladar sus investigaciones punteras del laboratorio a los pacientes

by CIC bioGUNE

Entre los seleccionados de este año se encuentran dos proyectos de CIC bioGUNE. Uno de ellos acercará a la práctica clínica una nueva terapia basada en anticuerpos para frenar la metástasis del c...

Read more

CIC bioGUNE researchers describe the presence of a tick molecular receptor able to respond to signals from the host

by CIC bioGUNE

The work, published in the journal Science, clarifies the evolutionary mechanisms in signalling pathways that are essential for performing key functions of environmental response (immune response) and...

Read more

Bowel habits written in the DNA: new clues for irritable bowel syndrome

by CIC bioGUNE

​ In a large-scale study published in Cell Genomics, researchers studied the DNA of more than 160,000 people who provided information on the frequency of their bowel movements. Genetic profiles and...

Read more

Jóvenes investigadores e investigadoras reciben formación para desarrollar vacunas innovadoras antibacterianas

by CIC bioGUNE

CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), is hosting until Thursday, 25 November, the congress of the BactiVax Project, a European training network funded by the Europ...

Read more

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

by CIC bioGUNE

The study, co-led by researchers from CIC bioGUNE, has analysed genetic data from over 50,000 patients. The research highlights the close relationship between brain and gut health and paves the way f...

Read more

Genetic defects and carbohydrate malabsorption lurking behind irritable bowel syndrome

by CIC bioGUNE

​A new study, led by researchers at CIC bioGUNE, suggests genetic defects in carbohydrates digestion may be (mis)diagnosed as IBS in some patients.

Read more

CIC bioGUNE, ONCE Foundation and Ikerbasque sign an agreement to promote the research career of people with disabilities in the field of health sciences

by CIC bioGUNE

The successful candidates will conduct their research at CIC bioGUNE. The aim of the collaboration agreement is to improve equal opportunity, universal accessibility, inclusion and non-discrimination...

Read more

CIC bioGUNE researchers describe a new microRNA determinant of response to sorafenib in patients with hepatocellular carcinoma

by CIC bioGUNE

Researchers from the Liver Disease Laboratory at CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), have described a new microRNA, a gene expression regulator molecule, which d...

Read more

Inhibition of a mitochondrial protein, a new therapeutic target for cholestatic liver diseases

by CIC bioGUNE

​The presence of this protein slows down the activity of the mitochondria, decreasing their ability to eliminate toxic substances such as certain bile acids.

Read more

BIOLAN y CIC bioGUNE desarrollarán conjuntamente un test ELISA para la detección de anticuerpos frente a SARS-CoV-2 y sus variantes

by CIC bioGUNE

Esta actuación de colaboración se enmarca en un acuerdo más amplio alcanzado entre CIC bioGUNE y BIOLAN en áreas encaminadas al diagnóstico de enfermedades y otras aplicaciones para la salud.

Read more

BIOLAN y CIC bioGUNE trabajan conjuntamente en el lanzamiento de un nuevo test serológico para el diagnóstico rápido de COVID-19

by CIC bioGUNE

Tecnología y Empresa vascas para responder a la prioridad impuesta por la pandemia, y que se enmarca en un acuerdo de colaboración más amplio alcanzado entre CIC bioGUNE y BIOLAN para el diagnósti...

Read more

CIC bioGUNE se sitúa entre los 100 mejores centros de investigación enbiomedicina del mundo según la revista Nature

by CIC bioGUNE

El ranking se basa en la cantidad y calidad de las publicaciones de los centros así como en el prestigio de los autores

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Remedi is born from the fusion of the co...

by Regenera Activa Worldwide

Regenera Activa Worldwide and Rigenera HBW, biotech firms specializing...

Photos Stream